158 related articles for article (PubMed ID: 25234729)
1. Alterations of the mTOR pathway in hepatic angiomyolipoma with emphasis on the epithelioid variant and loss of heterogeneity of TSC1/TSC2.
Huang SC; Chuang HC; Chen TD; Chi CL; Ng KF; Yeh TS; Chen TC
Histopathology; 2015 Apr; 66(5):695-705. PubMed ID: 25234729
[TBL] [Abstract][Full Text] [Related]
2. Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma.
Pan CC; Chung MY; Ng KF; Liu CY; Wang JS; Chai CY; Huang SH; Chen PC; Ho DM
J Pathol; 2008 Feb; 214(3):387-93. PubMed ID: 18085521
[TBL] [Abstract][Full Text] [Related]
3. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms.
Kenerson H; Folpe AL; Takayama TK; Yeung RS
Hum Pathol; 2007 Sep; 38(9):1361-71. PubMed ID: 17521703
[TBL] [Abstract][Full Text] [Related]
4. Hepatic angiomyolipoma: mutation analysis and immunohistochemical pitfalls in diagnosis.
Yan Z; Grenert JP; Joseph NM; Ren C; Chen X; Shafizadeh N; Kakar S
Histopathology; 2018 Jul; 73(1):101-108. PubMed ID: 29512829
[TBL] [Abstract][Full Text] [Related]
5. Renal angiomyolipoma: clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association.
Aydin H; Magi-Galluzzi C; Lane BR; Sercia L; Lopez JI; Rini BI; Zhou M
Am J Surg Pathol; 2009 Feb; 33(2):289-97. PubMed ID: 18852677
[TBL] [Abstract][Full Text] [Related]
6. Advanced sporadic renal epithelioid angiomyolipoma: case report of an extraordinary response to sirolimus linked to TSC2 mutation.
Espinosa M; Roldán-Romero JM; Duran I; de Álava E; Apellaniz-Ruiz M; Cascón A; Garrigos C; Robledo M; Rodriguez-Antona C
BMC Cancer; 2018 May; 18(1):561. PubMed ID: 29764404
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor is significantly associated with the epithelioid variants of renal angiomyolipoma: a clinicopathological and immunohistochemical study of 67 cases.
Cho NH; Shim HS; Choi YD; Kim DS
Pathol Int; 2004 Jul; 54(7):510-5. PubMed ID: 15189505
[TBL] [Abstract][Full Text] [Related]
8. [Differences in morphology and immunohistochemistry between hepatic angiomyolipoma and renal angiomyolipoma].
Shao Y; Zhong DR; Li XH
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1142-5. PubMed ID: 12921632
[TBL] [Abstract][Full Text] [Related]
9. Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development.
Giannikou K; Malinowska IA; Pugh TJ; Yan R; Tseng YY; Oh C; Kim J; Tyburczy ME; Chekaluk Y; Liu Y; Alesi N; Finlay GA; Wu CL; Signoretti S; Meyerson M; Getz G; Boehm JS; Henske EP; Kwiatkowski DJ
PLoS Genet; 2016 Aug; 12(8):e1006242. PubMed ID: 27494029
[TBL] [Abstract][Full Text] [Related]
10. Renal angiomyolipoma (AML) harboring a missense mutation of
Idogawa M; Hida T; Tanaka T; Ohira N; Tange S; Sasaki Y; Uhara H; Masumori N; Tokino T; Natori H
Cancer Biol Ther; 2020 Apr; 21(4):315-319. PubMed ID: 31847710
[TBL] [Abstract][Full Text] [Related]
11. Malignant angiomyolipoma in the liver: a case report with pathological and molecular analysis.
Deng YF; Lin Q; Zhang SH; Ling YM; He JK; Chen XF
Pathol Res Pract; 2008; 204(12):911-8. PubMed ID: 18723294
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentations and molecular studies of invasive renal epithelioid angiomyolipoma.
Chuang CK; Lin HCA; Tasi HY; Lee KH; Kao Y; Chuang FL; Chang YH; Lin PH; Liu CY; Pang ST
Int Urol Nephrol; 2017 Sep; 49(9):1527-1536. PubMed ID: 28547571
[TBL] [Abstract][Full Text] [Related]
13. Evidence Supporting a Lymphatic Endothelium Origin for Angiomyolipoma, a TSC2(-) Tumor Related to Lymphangioleiomyomatosis.
Yue M; Pacheco G; Cheng T; Li J; Wang Y; Henske EP; Schuger L
Am J Pathol; 2016 Jul; 186(7):1825-1836. PubMed ID: 27289491
[TBL] [Abstract][Full Text] [Related]
14. Monotypic epithelioid angiomyolipoma of the liver.
Yamasaki S; Tanaka S; Fujii H; Matsumoto T; Okuda C; Watanabe G; Suda K
Histopathology; 2000 May; 36(5):451-6. PubMed ID: 10792487
[TBL] [Abstract][Full Text] [Related]
15. Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants.
Tsui WM; Colombari R; Portmann BC; Bonetti F; Thung SN; Ferrell LD; Nakanuma Y; Snover DC; Bioulac-Sage P; Dhillon AP
Am J Surg Pathol; 1999 Jan; 23(1):34-48. PubMed ID: 9888702
[TBL] [Abstract][Full Text] [Related]
16. Role of mTOR signaling pathway in the pathogenesis of subependymal giant cell astrocytoma - A study of 28 cases.
Kumari K; Sharma MC; Kakkar A; Malgulwar PB; Pathak P; Suri V; Sarkar C; Chandra SP; Faruq M; Gupta RK; Saran RK
Neurol India; 2016; 64(5):988-94. PubMed ID: 27625244
[TBL] [Abstract][Full Text] [Related]
17. Primary monotypic epithelioid angiomyolipoma of bone.
Insabato L; De Rosa G; Terracciano LM; Fazioli F; Di Santo F; Rosai J
Histopathology; 2002 Mar; 40(3):286-90. PubMed ID: 11895495
[TBL] [Abstract][Full Text] [Related]
18. Renal epithelioid angiomyolipoma with malignant features: Histological evaluation and novel immunohistochemical findings.
Konosu-Fukaya S; Nakamura Y; Fujishima F; Kasajima A; McNamara KM; Takahashi Y; Joh K; Saito H; Ioritani N; Ikeda Y; Arai Y; Watanabe M; Sasano H
Pathol Int; 2014 Mar; 64(3):133-41. PubMed ID: 24698423
[TBL] [Abstract][Full Text] [Related]
19. PEComas: the past, the present and the future.
Martignoni G; Pea M; Reghellin D; Zamboni G; Bonetti F
Virchows Arch; 2008 Feb; 452(2):119-32. PubMed ID: 18080139
[TBL] [Abstract][Full Text] [Related]
20. The analysis of mutations and exon deletions at TSC2 gene in angiomyolipomas associated with tuberous sclerosis complex.
Yang HM; Choi HJ; Hong DP; Joo SY; Lee NE; Song JY; Choi YL; Lee J; Choi D; Kim B; Park HJ; Park JB; Kim SJ
Exp Mol Pathol; 2014 Dec; 97(3):440-4. PubMed ID: 25281918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
